Lack of effectiveness and seizure worsening with cenobamate in pediatric patients with Dravet syndrome

Documenti analoghi

• Fenfluramine treatment in pediatric patients with Dravet syndrome reduces seizure burden and overall healthcare costs: A retrospective and observational real‐world study
  di: Cathrine E. Gjerulfsen, et al.
  Pubblicazione: (2024)
• Pharmacological management of prolonged seizures in Dravet syndrome including intravenous phenytoin
  di: Rana Abi Tayeh, et al.
  Pubblicazione: (2024)
• Hippocampal malformation in Dravet syndrome
  di: Nishad Esdor Okutoyi, et al.
  Pubblicazione: (2026)
• Nonseizure symptoms and broader seizure impacts in patients with Dravet syndrome and Lennox–Gastaut syndrome in clinical practice settings: Results from a multinational survey
  di: Drishti Shah, et al.
  Pubblicazione: (2025)
• Consensus panel recommendations for the optimization of EPIDIOLEX® treatment for seizures associated with Lennox–Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex
  di: Robert T. Wechsler, et al.
  Pubblicazione: (2024)